Coronary Artery Disease and Atrial Fibrillation in HighBleeding Risk: Indications and Optimal Antithrombotic Therapy After Percutaneous Left Atrial Appendage Occlusion.

Mazzapicchi A, Gallo F, Zanarelli L, Filice F, Trichilo M, Ielasi A, Tespili M, Grassi M, Semeraro GC, De Luca G, Giannini F

Open source

DOI
10.3390/jcm15187181
Published
2026 Sep 16
Container
Journal of clinical medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm15187181,
  title = {Coronary Artery Disease and Atrial Fibrillation in HighBleeding Risk: Indications and Optimal Antithrombotic Therapy After Percutaneous Left Atrial Appendage Occlusion.},
  author = {Mazzapicchi A and Gallo F and Zanarelli L and Filice F and Trichilo M and Ielasi A and Tespili M and Grassi M and Semeraro GC and De Luca G and Giannini F},
  year = {2026},
  journal = {Journal of clinical medicine},
  doi = {10.3390/jcm15187181},
  url = {https://doi.org/10.3390/jcm15187181}
}

RIS

TY  - JOUR
TI  - Coronary Artery Disease and Atrial Fibrillation in HighBleeding Risk: Indications and Optimal Antithrombotic Therapy After Percutaneous Left Atrial Appendage Occlusion.
AU  - Mazzapicchi A
AU  - Gallo F
AU  - Zanarelli L
AU  - Filice F
AU  - Trichilo M
AU  - Ielasi A
AU  - Tespili M
AU  - Grassi M
AU  - Semeraro GC
AU  - De Luca G
AU  - Giannini F
PY  - 2026
JO  - Journal of clinical medicine
DO  - 10.3390/jcm15187181
UR  - https://doi.org/10.3390/jcm15187181
ER  - 

APA

A, M., F, G., L, Z., F, F., M, T., A, I., M, T., M, G., GC, S., G, D. L., & F, G. (2026). Coronary Artery Disease and Atrial Fibrillation in HighBleeding Risk: Indications and Optimal Antithrombotic Therapy After Percutaneous Left Atrial Appendage Occlusion.. Journal of clinical medicine. https://doi.org/10.3390/jcm15187181

Source records